These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 27173919)

  • 1. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
    Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
    Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis.
    Suades R; Padró T; Alonso R; Mata P; Badimon L
    Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease.
    Almquist T; Mobarrez F; Jacobson SH; Wallén H; Hjemdahl P
    Nephrol Dial Transplant; 2016 Jun; 31(6):944-52. PubMed ID: 26394646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
    Christersson C; Thulin Å; Siegbahn A
    Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of microparticles in diabetic vascular complications.
    Tsimerman G; Roguin A; Bachar A; Melamed E; Brenner B; Aharon A
    Thromb Haemost; 2011 Aug; 106(2):310-21. PubMed ID: 21713319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques.
    Suades R; Padró T; Vilahur G; Badimon L
    Thromb Haemost; 2012 Dec; 108(6):1208-19. PubMed ID: 23138460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis.
    Morel O; Kessler L; Ohlmann P; Bareiss P
    Atherosclerosis; 2010 Oct; 212(2):367-76. PubMed ID: 20394927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic role of microparticles in type 2 diabetes mellitus.
    Nomura S
    Curr Diabetes Rev; 2009 Nov; 5(4):245-51. PubMed ID: 19531024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma microparticles in Alzheimer's disease: The role of vascular dysfunction.
    Hosseinzadeh S; Noroozian M; Mortaz E; Mousavizadeh K
    Metab Brain Dis; 2018 Feb; 33(1):293-299. PubMed ID: 29209923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microparticle and Atherothrombotic Diseases.
    Nomura S
    J Atheroscler Thromb; 2016; 23(1):1-9. PubMed ID: 26412494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased microparticle levels in middle-aged and elderly patients with insomnia may be involved in the pathogenesis of arteriosclerosis.
    Xu B; Ma L; Zhang N; Guo W; Luo LM; Wang C; Jiang Y; Liu LG
    Int Angiol; 2020 Jun; 39(3):252-260. PubMed ID: 32052947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meal intake increases circulating procoagulant microparticles in patients with type 1 and type 2 diabetes mellitus.
    Spectre G; Mobarrez F; Stålesen R; Östenson CG; Varon D; Wallen H; Hjemdahl P
    Platelets; 2019; 30(3):348-355. PubMed ID: 29547014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis.
    Berezin AE; Kremzer AA; Berezina TA; Martovitskaya YV
    Acta Clin Belg; 2016 Feb; 71(1):38-45. PubMed ID: 27075791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of microparticles in the injured brain of patients with severe isolated traumatic brain injury.
    Nekludov M; Mobarrez F; Gryth D; Bellander BM; Wallen H
    J Neurotrauma; 2014 Dec; 31(23):1927-33. PubMed ID: 24956150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microparticles as biomarkers of stroke: A focus on the value of endothelial- and platelet-derived microparticles.
    El-Gamal H; Parray AS; Mir FA; Shuaib A; Agouni A
    J Cell Physiol; 2019 Aug; 234(10):16739-16754. PubMed ID: 30912147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procoagulant microparticles: disrupting the vascular homeostasis equation?
    Morel O; Toti F; Hugel B; Bakouboula B; Camoin-Jau L; Dignat-George F; Freyssinet JM
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2594-604. PubMed ID: 16990554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial microparticle-associated protein disulfide isomerase increases platelet activation in diabetic coronary heart disease.
    Sun XD; Han L; Lan HT; Qin RR; Song M; Zhang W; Zhong M; Wang ZH
    Aging (Albany NY); 2021 Jul; 13(14):18718-18739. PubMed ID: 34285139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microparticle Shedding by Erythrocytes, Monocytes and Vascular Smooth Muscular Cells Is Reduced by Aspirin in Diabetic Patients.
    Chiva-Blanch G; Suades R; Padró T; Vilahur G; Peña E; Ybarra J; Pou JM; Badimon L
    Rev Esp Cardiol (Engl Ed); 2016 Jul; 69(7):672-80. PubMed ID: 27103451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.